Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 1/2024

26.07.2023 | Original Article

p53, Cytokeratin 19 Expression in Oral Squamous Cell Carcinoma and Correlation with Histopathologic Grading: An Immunohistochemical Study

verfasst von: Harpreet Kaur, Vinay Hazarey, Gitika Sharma, Suchitra Gosavi, Rana AGK Pal, Vandana Gupta

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to examine the immunohistochemical expression of p53 and cytokeratin 19 (CK19) in normal oral mucosa (NOM) and oral squamous cell carcinoma (OSCC) and their association with histopathological differentiation grade. The secondary goal was to see if there was any correlation between p53 and CK19 expression in NOM and OSCC. A hospital-based retrospective analysis was conducted in which 40 NOM and 45 OSCC samples were acquired from archives and stained with mouse monoclonal antibodies p53 and CK19. For both the NOM and OSCC groups, the proportion of positively stained cells, staining intensity, and staining index were calculated. p53 immunoexpression revealed that 85% of positively stained cells in the NOM basal layer had a low staining index (mean ± SD 1.87 ± 0.34), whereas 66.7% of positively stained cells in the OSCC had a high staining index (mean ± SD 5.63 ± 3.02). When NOM and OSCC were compared, there was a statistically significant difference in staining intensity. However, despite a linear increase in the percentage of positive cells from well to poorly differentiated, the comparison between histopathological grades was non-significant. CK19 exhibited 18.5% positively stained cells in the NOM basal layer with a low staining index (mean ± SD 1.57 ± 0.53), whereas OSCC samples showed 4.44% immunopositivity with a high staining index. p53 is a marker of oral carcinogenesis independent of histological grade and CK19 expression. Further, CK19 is a marker of dysfunctional epithelial differentiation but lacks sensitivity and specificity; however, it demands further multicentric studies with a large sample size to draw definitive conclusions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gupta B, Johnson NW, Kumar N (2016) Global epidemiology of head and neck cancers: a continuing challenge. Oncology 91:13–23PubMedCrossRef Gupta B, Johnson NW, Kumar N (2016) Global epidemiology of head and neck cancers: a continuing challenge. Oncology 91:13–23PubMedCrossRef
3.
Zurück zum Zitat Johnson NW (1991) Orofacial neoplasms: global epidemiology, risk factors and recommendations for research. Int Dent J 41:365–375PubMed Johnson NW (1991) Orofacial neoplasms: global epidemiology, risk factors and recommendations for research. Int Dent J 41:365–375PubMed
4.
Zurück zum Zitat Funk GF, Karnell LH, Robinson RA, Zen WK, Trask DK, Hoffman HT (2002) Presentation, treatment and outcome of oral cavity cancer: a national cancer data data base report. Head Neck 24:165–180PubMedCrossRef Funk GF, Karnell LH, Robinson RA, Zen WK, Trask DK, Hoffman HT (2002) Presentation, treatment and outcome of oral cavity cancer: a national cancer data data base report. Head Neck 24:165–180PubMedCrossRef
5.
Zurück zum Zitat Platz H, Fries R, Fries R, Hudec M (1985) Retrospective DOSAK study on carcinomas of the oral cavity: results and consequences. J Maxillofac Surg 13:147–153PubMedCrossRef Platz H, Fries R, Fries R, Hudec M (1985) Retrospective DOSAK study on carcinomas of the oral cavity: results and consequences. J Maxillofac Surg 13:147–153PubMedCrossRef
6.
Zurück zum Zitat Snow GB, Patel P, Leemans CR, Tiwari R (1992) Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 249:187–194PubMedCrossRef Snow GB, Patel P, Leemans CR, Tiwari R (1992) Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 249:187–194PubMedCrossRef
7.
Zurück zum Zitat Yamamoto E, Miyakawa A, Kohama G (1984) Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg 6:938–947PubMedCrossRef Yamamoto E, Miyakawa A, Kohama G (1984) Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg 6:938–947PubMedCrossRef
8.
Zurück zum Zitat Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Suárez C, Kowalski LP, Ferlito A, Leivo I (2020) Staging and grading of oral squamous cell carcinoma: An update. Oral oncology. Aug 1;107:104799 Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Suárez C, Kowalski LP, Ferlito A, Leivo I (2020) Staging and grading of oral squamous cell carcinoma: An update. Oral oncology. Aug 1;107:104799
9.
Zurück zum Zitat Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24PubMedCrossRef Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24PubMedCrossRef
10.
Zurück zum Zitat Moll R, Krepler R, Franke WW (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23:256–269PubMedCrossRef Moll R, Krepler R, Franke WW (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23:256–269PubMedCrossRef
11.
Zurück zum Zitat Wu YJ, Rheinwald JG (1981) A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas. Cell 25:627–635PubMedCrossRef Wu YJ, Rheinwald JG (1981) A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas. Cell 25:627–635PubMedCrossRef
12.
Zurück zum Zitat Sugama Y, Kitamura S, Kawai T, Ohkubo A, Hasegawa S, Kuriyama T et al (1994) Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment. Jpn J Cancer Res 85:1178–1184PubMedPubMedCentralCrossRef Sugama Y, Kitamura S, Kawai T, Ohkubo A, Hasegawa S, Kuriyama T et al (1994) Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment. Jpn J Cancer Res 85:1178–1184PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Wieskopf B, Demangeat C, Purohit A, Strenger R, Gries P, Kreisman H et al (1995) Cyfa21- 1 as a biologic marker of non-small cell lung cancer. Chest 108:163–169PubMedCrossRef Wieskopf B, Demangeat C, Purohit A, Strenger R, Gries P, Kreisman H et al (1995) Cyfa21- 1 as a biologic marker of non-small cell lung cancer. Chest 108:163–169PubMedCrossRef
14.
Zurück zum Zitat Takahashi H, Kurishima K, Ishikawa H (2010) Optimal cutoff points of CYFRA21-1 for survival prediction in non‐small cell lung cancer patients based on running statistical analysis. Anticancer Res 30:3833–3837PubMed Takahashi H, Kurishima K, Ishikawa H (2010) Optimal cutoff points of CYFRA21-1 for survival prediction in non‐small cell lung cancer patients based on running statistical analysis. Anticancer Res 30:3833–3837PubMed
15.
Zurück zum Zitat Khanna R, Vidhyarthi AK, Khanna S, Singh S, Singh UC (2012) Expression of p53 protein in Leukoplakia and oral squamous cell carcinoma. World J Surg Med Radiation Oncol 1:16 Khanna R, Vidhyarthi AK, Khanna S, Singh S, Singh UC (2012) Expression of p53 protein in Leukoplakia and oral squamous cell carcinoma. World J Surg Med Radiation Oncol 1:16
16.
Zurück zum Zitat Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H (1998) Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:438–443PubMedCrossRef Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H (1998) Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:438–443PubMedCrossRef
17.
Zurück zum Zitat Nylander K, Dabelsteen E, Hall PA (2000) The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29:413–425PubMedCrossRef Nylander K, Dabelsteen E, Hall PA (2000) The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29:413–425PubMedCrossRef
18.
Zurück zum Zitat Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG (2011) Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res 25:34–41PubMedCrossRef Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG (2011) Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res 25:34–41PubMedCrossRef
19.
Zurück zum Zitat Li L, Fukumoto M, Liu D (2013) Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy. Oncol Lett 6(1):1611–1615PubMedPubMedCentralCrossRef Li L, Fukumoto M, Liu D (2013) Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy. Oncol Lett 6(1):1611–1615PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Cui XS, Donehower LA (2000 Dec) Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Oncogene 19:5988–5996 Cui XS, Donehower LA (2000 Dec) Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Oncogene 19:5988–5996
21.
Zurück zum Zitat Kale AD, Mane DR, Babji D, Gupta K (2012) Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: a immunohistochemical study. J Oral Maxillofac Pathol 16:10–15PubMedPubMedCentralCrossRef Kale AD, Mane DR, Babji D, Gupta K (2012) Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: a immunohistochemical study. J Oral Maxillofac Pathol 16:10–15PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Safadi RA, Musleh AS, Al-Khateeb TH, Hamasha AA (2010) Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method. Head Neck Pathol 4:282–289PubMedPubMedCentralCrossRef Safadi RA, Musleh AS, Al-Khateeb TH, Hamasha AA (2010) Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method. Head Neck Pathol 4:282–289PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Rao RS, Patil S, Ganavi BS Oral cytokeratins in health and disease. J Contemp Dent Pract. 2014 Jan 1;15(1):127 – 36 Rao RS, Patil S, Ganavi BS Oral cytokeratins in health and disease. J Contemp Dent Pract. 2014 Jan 1;15(1):127 – 36
24.
Zurück zum Zitat Lindberg K, Rheinwald JG (1989) Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 134:89PubMedPubMedCentral Lindberg K, Rheinwald JG (1989) Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 134:89PubMedPubMedCentral
25.
Zurück zum Zitat Babiker AY, Rahmani AH, Abdalaziz MS, Albutti A, Aly SM, Ahmed HG (2014) Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients. Int J Clin Exp Med 7:1524–1530PubMedPubMedCentral Babiker AY, Rahmani AH, Abdalaziz MS, Albutti A, Aly SM, Ahmed HG (2014) Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients. Int J Clin Exp Med 7:1524–1530PubMedPubMedCentral
26.
Zurück zum Zitat Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR (2003) Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 82:34–50PubMedCrossRef Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR (2003) Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 82:34–50PubMedCrossRef
27.
Zurück zum Zitat Frohwitter G, Buerger H, Van Diest PJ, Korsching E, Kleinheinz J, Fillies T (2016) Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett 12:107–113PubMedPubMedCentralCrossRef Frohwitter G, Buerger H, Van Diest PJ, Korsching E, Kleinheinz J, Fillies T (2016) Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett 12:107–113PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H (2007) Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep 18:639–643PubMed Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H (2007) Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep 18:639–643PubMed
29.
Zurück zum Zitat Crowe DL, Milo GE, Shuler CE (1999) Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 78:1256–1263PubMedCrossRef Crowe DL, Milo GE, Shuler CE (1999) Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 78:1256–1263PubMedCrossRef
30.
Zurück zum Zitat Molès JP, Schiller JT, Tesniere A, Leigh IM, Guilhou JJ, Basset-Séguin N (1994) Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sc 107:435–441CrossRef Molès JP, Schiller JT, Tesniere A, Leigh IM, Guilhou JJ, Basset-Séguin N (1994) Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sc 107:435–441CrossRef
31.
Zurück zum Zitat Soussi T (2000) The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 910:121–139ADSPubMedCrossRef Soussi T (2000) The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 910:121–139ADSPubMedCrossRef
32.
Zurück zum Zitat Oliveira LR, Ribeiro-Silva A (2011) Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 40:298–307PubMedCrossRef Oliveira LR, Ribeiro-Silva A (2011) Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 40:298–307PubMedCrossRef
33.
Zurück zum Zitat Bhargava A, Saigal S, Chalishazar M (2010) Histopathological grading systems in oral squamous cell carcinoma: a review. J Int Oral Health 2:1–10 Bhargava A, Saigal S, Chalishazar M (2010) Histopathological grading systems in oral squamous cell carcinoma: a review. J Int Oral Health 2:1–10
34.
Zurück zum Zitat Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddin M (2009) Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol 38:625–643CrossRef Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddin M (2009) Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol 38:625–643CrossRef
35.
Zurück zum Zitat Kumar Shukla N, Deo SS, Jakhetiya A, Manjunath NM, Sreenivas V, Thulkar S et al (2018) Clinical spectrum, treatment and relapse patterns in 353 patients with squamous cell carcinoma of the Alveobuccal Complex treated with a curative intent: a retrospective study. J Maxillofac Oral Surg 17:24–31CrossRef Kumar Shukla N, Deo SS, Jakhetiya A, Manjunath NM, Sreenivas V, Thulkar S et al (2018) Clinical spectrum, treatment and relapse patterns in 353 patients with squamous cell carcinoma of the Alveobuccal Complex treated with a curative intent: a retrospective study. J Maxillofac Oral Surg 17:24–31CrossRef
36.
Zurück zum Zitat Ries JC, Schreiner D, Steininger H, Girod SC (1998) p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma. Anticancer Res 18(3B):2031–2036PubMed Ries JC, Schreiner D, Steininger H, Girod SC (1998) p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma. Anticancer Res 18(3B):2031–2036PubMed
37.
Zurück zum Zitat Verma R, Singh A, Jaiswal R, Chandra A, Verma R, Tak J (2014) Association of Ki 67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma. Indian J Pathol Microbiol 57:553–557PubMedCrossRef Verma R, Singh A, Jaiswal R, Chandra A, Verma R, Tak J (2014) Association of Ki 67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma. Indian J Pathol Microbiol 57:553–557PubMedCrossRef
38.
Zurück zum Zitat Montebugnoli L, Felicetti L, Gissi DB, Cervellati F, Servidio D, Marchetti C et al (2008) Predictive role of p53 protein as a single marker or associated to Ki67 antigen in oral carcinogenesis. Open Dent J 2:24–29PubMedPubMedCentralCrossRef Montebugnoli L, Felicetti L, Gissi DB, Cervellati F, Servidio D, Marchetti C et al (2008) Predictive role of p53 protein as a single marker or associated to Ki67 antigen in oral carcinogenesis. Open Dent J 2:24–29PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Bidaud P, Chasle J, Sichel F, Rousseau S, Petit P, Pottier D et al (2010) Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis. Histol Histopathol 25:331–339PubMed Bidaud P, Chasle J, Sichel F, Rousseau S, Petit P, Pottier D et al (2010) Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis. Histol Histopathol 25:331–339PubMed
40.
Zurück zum Zitat Yang L, Wang Y, Guo L, Wang L, Chen W, Shi B (2015) The expression and correlation of iNOS and p53 in oral squamous cell carcinoma. Biomed Res Int. ; 2015: 637853 Yang L, Wang Y, Guo L, Wang L, Chen W, Shi B (2015) The expression and correlation of iNOS and p53 in oral squamous cell carcinoma. Biomed Res Int. ; 2015: 637853
41.
Zurück zum Zitat Cuevas Gonzalez JC, Gaitan Cepeda LA, Borges Yanez SA, Cornejo AD, Mori Estevez AD, Huerta ER (2016) p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: a study of 208 cases. Indian J Pathol Microbiol 59(2):153–158PubMedCrossRef Cuevas Gonzalez JC, Gaitan Cepeda LA, Borges Yanez SA, Cornejo AD, Mori Estevez AD, Huerta ER (2016) p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: a study of 208 cases. Indian J Pathol Microbiol 59(2):153–158PubMedCrossRef
42.
Zurück zum Zitat Swaminathan U, Joshua E, Rao UK, Ranganathan K (2012) Expression of p53 and cyclin D1 in oral squamous cell carcinoma and normal mucosa: an immunohistochemical study. J Oral Maxillofac Pathol 16:172–177PubMedPubMedCentralCrossRef Swaminathan U, Joshua E, Rao UK, Ranganathan K (2012) Expression of p53 and cyclin D1 in oral squamous cell carcinoma and normal mucosa: an immunohistochemical study. J Oral Maxillofac Pathol 16:172–177PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Hashmi AA, Hussain ZF, Hashmi SK, Irfan M, Khan EY, Faridi N et al (2018) Immunohistochemical over expression of p53 in head and neck squamous cell carcinoma: clinical and prognostic significance. BMC Res Notes 11:433PubMedPubMedCentralCrossRef Hashmi AA, Hussain ZF, Hashmi SK, Irfan M, Khan EY, Faridi N et al (2018) Immunohistochemical over expression of p53 in head and neck squamous cell carcinoma: clinical and prognostic significance. BMC Res Notes 11:433PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Kannan S, Chandran GJ, Pillai KR, Mathew B, Sujathan K, Nalinakumary KR et al (1996) Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67. Clin Mol Pathol 49:170–175CrossRef Kannan S, Chandran GJ, Pillai KR, Mathew B, Sujathan K, Nalinakumary KR et al (1996) Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67. Clin Mol Pathol 49:170–175CrossRef
45.
Zurück zum Zitat Kerdpon D, Rich AM, Reade PC (1997) Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 3:86–92PubMedCrossRef Kerdpon D, Rich AM, Reade PC (1997) Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 3:86–92PubMedCrossRef
46.
Zurück zum Zitat Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A et al (2005) Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 18:1482–1489PubMedCrossRef Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A et al (2005) Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 18:1482–1489PubMedCrossRef
47.
Zurück zum Zitat Siegelmann-Danieli N, Ben-Izhack O, Hanlon A, Ridge JA, Stein ME, Khandelwal V et al (2005) P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori 91:346–350PubMedCrossRef Siegelmann-Danieli N, Ben-Izhack O, Hanlon A, Ridge JA, Stein ME, Khandelwal V et al (2005) P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori 91:346–350PubMedCrossRef
48.
Zurück zum Zitat Abbas NF, El-Sharkawy SL, Abbas EA, El-Shaer MA (2007) Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:385–390PubMedCrossRef Abbas NF, El-Sharkawy SL, Abbas EA, El-Shaer MA (2007) Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:385–390PubMedCrossRef
49.
Zurück zum Zitat Jain A, Maheshwari V, Mehdi G, Alam K, Sharma SC (2008) Diagnostic and prognostic significance of p53 protein expression in squamous cell lesions of the oral cavity. Int J Otorhinolaryngol 7:45–49 Jain A, Maheshwari V, Mehdi G, Alam K, Sharma SC (2008) Diagnostic and prognostic significance of p53 protein expression in squamous cell lesions of the oral cavity. Int J Otorhinolaryngol 7:45–49
50.
Zurück zum Zitat De Oliveira LR, Ribeiro-Silva A, Zucoloto S (2007) Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 36(4):191–197PubMedCrossRef De Oliveira LR, Ribeiro-Silva A, Zucoloto S (2007) Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 36(4):191–197PubMedCrossRef
51.
Zurück zum Zitat Nie MH, Zhong L, Zeng GM, Li BQ (2002) The changes of cytokeratin 19 during oral carcinogenesis. Chin J Stomatol 37:187–191 Nie MH, Zhong L, Zeng GM, Li BQ (2002) The changes of cytokeratin 19 during oral carcinogenesis. Chin J Stomatol 37:187–191
52.
Zurück zum Zitat Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H (1998) Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:438–443PubMedCrossRef Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H (1998) Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:438–443PubMedCrossRef
53.
Zurück zum Zitat Babiker AY, Rahmani AH, Abdalaziz MS, Albutti A, Aly SM, Ahmed HG (2014) Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients. Int J Clin Exp Med 7:1524–1530PubMedPubMedCentral Babiker AY, Rahmani AH, Abdalaziz MS, Albutti A, Aly SM, Ahmed HG (2014) Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients. Int J Clin Exp Med 7:1524–1530PubMedPubMedCentral
54.
Zurück zum Zitat Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR (2003) Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 82:34–50PubMedCrossRef Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR (2003) Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 82:34–50PubMedCrossRef
Metadaten
Titel
p53, Cytokeratin 19 Expression in Oral Squamous Cell Carcinoma and Correlation with Histopathologic Grading: An Immunohistochemical Study
verfasst von
Harpreet Kaur
Vinay Hazarey
Gitika Sharma
Suchitra Gosavi
Rana AGK Pal
Vandana Gupta
Publikationsdatum
26.07.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 1/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-04092-7

Weitere Artikel der Ausgabe 1/2024

Indian Journal of Otolaryngology and Head & Neck Surgery 1/2024 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.